Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Dynavax Technologies (NQ: DVAX )

9.880 USD +0.140 (+1.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,812,435
Open 9.700
Bid (Size) 9.930 (1)
Ask (Size) 9.900 (4)
Prev. Close 9.740
Today's Range 9.665 - 10.00
52wk Range 3.580 - 11.84
Shares Outstanding 114,760,092
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Dynavax Announces Second Quarter 2021 Financial Results
- Second quarter 2021 total revenue of $52.8 million, which includes HEPLISAV-B's highest quarterly revenue to date at $13.7 million 
From PR Newswire
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 438,000 shares of Dynavax common stock as inducements to 44... 
From PR Newswire

Performance

YTD
+113.85%
+113.85%
1 Month
+4.00%
+4.00%
3 Month
+10.51%
+10.51%
6 Month
+4.99%
+4.99%
1 Year
+9.90%
+9.90%

More News

Read More
Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021
From PR Newswire
Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate
From PR Newswire
Valneva to Host Symposium on COVID-19 and Chikungunya Vaccine Candidates at 31st European Congress of Clinical Microbiology & Infectious Diseases
From GlobeNewswire News Releases
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration
From PR Newswire
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
From PR Newswire
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
From PR Newswire
Dynavax Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Dynavax to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.